Inhibitoren

Click on the specific product, view the latest information of the products, serving information
Structure Chemical Name CAS MF
3,3'-(2,4-Diamino-6,7-pteridinediyl)bisphenol 3,3'-(2,4-Diamino-6,7-pteridinediyl)bisphenol 677297-51-7 C18H14N6O2
PIK-294 PIK-294 900185-02-6 C28H23N7O2
PIK-75 Hydrochloride PIK-75 Hydrochloride 372196-77-5 C16H15BrClN5O4S
PKI-402 PKI-402 1173204-81-3 C29H34N10O3
XL765 XL765 1349796-36-6 C31H29N5O6S
5-[[4-(4-Pyridinyl)-6-quinolinyl]methylene]-2,4-thiazolidenedione 5-[[4-(4-Pyridinyl)-6-quinolinyl]methylene]-2,4-thiazolidenedione 958852-01-2 C18H11N3O2S
VS-5584 VS-5584 1246560-33-7 C17H22N8O
CZC24832 CZC24832 1159824-67-5 C15H17FN6O2S
A66 A66 1166227-08-2 C17H23N5O2S2
NVP-BGT226 NVP-BGT226 1245537-68-1 C28H25F3N6O2.C4H4O4
BAY 80-6946 (Copanlisib) BAY 80-6946 (Copanlisib) 1032568-63-0 C23H28N8O4
2-[[(1R)-1-[7-methyl-2-(4-morpholinyl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid 2-[[(1R)-1-[7-methyl-2-(4-morpholinyl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid 1173900-33-8 C22H24N4O4
CH5132799 CH5132799 1007207-67-1 C15H19N7O3S
AS 604850 AS 604850 648449-76-7 C11H5F2NO4S
(-)-MK-801 MALEATE (-)-MK-801 MALEATE 121917-57-5 C20H19NO4
N-(4-Chloro-3-methoxyphenyl)-2-pyridinecarboxamide N-(4-Chloro-3-methoxyphenyl)-2-pyridinecarboxamide 1161205-04-4 C13H11ClN2O2
VU 0357121 VU 0357121 433967-28-3 C17H17F2NO2
LY-404039 LY-404039 635318-11-5 C7H9NO6S
AVL-292 AVL-292 1202757-89-8 C22H22FN5O3
LY310762 LY310762 192927-92-7 C24H27O2N2FHCl
LY 2874455 LY 2874455 1254473-64-7 C21H19Cl2N5O2
WZ8040 WZ8040 1214265-57-2 C24H25ClN6OS
5-(3-Benzyloxyphenyl)-7-[trans-3-[(pyrrolidin-1-yl)methyl]cyclobutyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine 5-(3-Benzyloxyphenyl)-7-[trans-3-[(pyrrolidin-1-yl)methyl]cyclobutyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine 475488-23-4 C28H31N5O
OSI-420 OSI-420 183320-51-6 C21H22ClN3O4
Ciproxifan Ciproxifan 184025-18-1 C16H18N2O2
BRL 54443 BRL 54443 57477-39-1 C14H18N2O
AVP-AEW541 AVP-AEW541 475489-16-8 C27H29N5O
ALK/IGF1R inhibitor ALK/IGF1R inhibitor 1356962-20-3 C24H25ClN6O
ZM 306416 ZM 306416 690206-97-4 C16H13ClFN3O2
Dexmedetomidine Dexmedetomidine 113775-47-6 C13H16N2
3-[(2,4-Dimethylpyrrol-5-yl)methylidenyl]-2-indolinon 3-[(2,4-Dimethylpyrrol-5-yl)methylidenyl]-2-indolinon 194413-58-6 C15H14N2O
AMG-208 AMG-208 1002304-34-8 C22H17N5O2
KRN 633 KRN 633 286370-15-8 C20H21ClN4O4
R428 R428 1037624-75-1 C30H34N8
CP-724714 CP-724714 537705-08-1 C27H27N5O3
BRL 15572 HYDROCHLORIDE BRL 15572 HYDROCHLORIDE 193611-72-2 C25H28Cl2N2O
NVP-BVU 972 NVP-BVU 972 1185763-69-2 C20H16N6
TYRPHOSTIN AG 1024 TYRPHOSTIN AG 1024 65678-07-1 C14H13BrN2O
PD153035 HCl PD153035 HCl 183322-45-4 C16H14BrN3O2.HCl
Ziprasidone Ziprasidone 122883-93-6 C21H21ClN4OS
AMG 458 AMG 458 913376-83-7 C30H29N5O5
ARRY-380 ARRY-380 937265-83-3 C29H27N7O4S
N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine 1097917-15-1 C29H40N8O3S
IGF-1R  Inhibitor  II,  N-(5-Chloro-2-methoxyphenyl)-Nμ-(2-methylquinolin-4-yl)urea IGF-1R Inhibitor II, N-(5-Chloro-2-methoxyphenyl)-Nμ-(2-methylquinolin-4-yl)urea 196868-63-0 C18H16ClN3O2
5-[3-Methoxy-4-(4-methoxy-benzyloxy)-benzyl]-pyrimidine-2,4-diamine 5-[3-Methoxy-4-(4-methoxy-benzyloxy)-benzyl]-pyrimidine-2,4-diamine 870483-87-7 C20H22N4O3
1-{2-[5-(2-Methoxy-ethoxy)-benzoimidazol-1-yl]-quinolin-8-yl}-piperidin-4-ylamine 1-{2-[5-(2-Methoxy-ethoxy)-benzoimidazol-1-yl]-quinolin-8-yl}-piperidin-4-ylamine 343787-29-1 C24H27N5O2
NVP-BHG712 NVP-BHG712 940310-85-0 C26H20F3N7O
TAK-285 TAK-285 871026-44-7 C26H25ClF3N5O3
MGluR5 inhibitor MGluR5 inhibitor 871362-31-1 C19H13ClF3N3O
JNJ7777120 JNJ7777120 459168-41-3 C14H16ClN3O
3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-pyrrolidine-2,5-dione 3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-pyrrolidine-2,5-dione 905854-02-6 C23H19N3O2
4-(4-FLUORO-1-NAPHTHALENYL)-6-(1-METHYLETHYL)-2-PYRIMIDINAMINE HYDROCHLORIDE 4-(4-FLUORO-1-NAPHTHALENYL)-6-(1-METHYLETHYL)-2-PYRIMIDINAMINE HYDROCHLORIDE 199864-87-4 C17H16FN3
Capmatinib Capmatinib 1029712-80-8 C23H17FN6O
4-(Diphenylmethylen)-1,1-dimethyl-piperidinium-methyl-sulfat 4-(Diphenylmethylen)-1,1-dimethyl-piperidinium-methyl-sulfat 62-97-5 C20H24N.CH3O4S
BMS-754807 BMS-754807 1001350-96-4 C23H24FN9O
Tie2 kinase inhibitor Tie2 kinase inhibitor 948557-43-5 C26H21N3O2S
BMS-794833 BMS-794833 1174046-72-0 C23H15ClF2N4O3
Lorlatinib Lorlatinib 1454846-35-5 C21H19FN6O2
LRRK2-IN-1 LRRK2-IN-1 1234480-84-2 C31H38N8O3
ARRY-334543 ARRY-334543 845272-21-1 C22H19ClN6O2S
Golvatinib (E7050) Golvatinib (E7050) 928037-13-2 C33H37F2N7O4
2-(2-ETHYL-2,3-DIHYDRO-2-BENZOFURANYL)-1H-IMIDAZOLE 2-(2-ETHYL-2,3-DIHYDRO-2-BENZOFURANYL)-1H-IMIDAZOLE 189224-48-4 C13H14N2O
Mk-2461  . Mk-2461 . 917879-39-1 C24H25N5O5S
Insulin-like Growth Factor-1 Receptor Inhibitor Insulin-like Growth Factor-1 Receptor Inhibitor 468740-43-4 C25H26ClN5O3
SR 1078 SR 1078 1246525-60-9 C17H10F9NO2
AST-1306 AST-1306 1050500-29-2 C31H26ClFN4O5S
Poziotinib (HM781-36B) Poziotinib (HM781-36B) 1092364-38-9 C23H21Cl2FN4O3
Mycophenolate mofetil Mycophenolate mofetil 115007-34-6 C23H31NO7
lenvatinib Mesylate lenvatinib Mesylate 857890-39-2 C22H23ClN4O7S
Tacrolimus Monohydrate Tacrolimus Monohydrate 109581-93-3 C44H71NO13
OSI-930 OSI-930 728033-96-3 C22H16F3N3O2S
HS-173 HS-173 1276110-06-5 C21H18N4O4S
UNC2881 UNC2881 1493764-08-1 C25H33N7O2
REVERSINE REVERSINE 656820-32-5 C21H27N7O
4,4'-Propylenbis(piperazin-2,6-dion) 4,4'-Propylenbis(piperazin-2,6-dion) 21416-67-1 C11H16N4O4
SB269970 HCl SB269970 HCl 261901-57-9 C18H28N2O3SHCl
NVP-BSK805 NVP-BSK805 1092499-93-8 C27H28F2N6O
3-(1-Methyl-1H-pyrazol-4-yl)-5-oxo-N-(2-pyridinylmethyl)-5H-benzo[4,5]cyclohepta[1,2-b]pyridine-7-methanesulfonamide 3-(1-Methyl-1H-pyrazol-4-yl)-5-oxo-N-(2-pyridinylmethyl)-5H-benzo[4,5]cyclohepta[1,2-b]pyridine-7-methanesulfonamide 1001917-37-8 C25H21N5O3S
E-3810 E-3810 1058137-23-7 C26H25N3O4
DCC-2618 DCC-2618 1225278-16-9 C26H21F2N5O3
GNF 5837 GNF 5837 1033769-28-6 C28H21F4N5O2
ANA12 ANA12 219766-25-3 C22H21N3O3S
ADX-47273 ADX-47273 851881-60-2 C20H17F2N3O2
Tepotinib Tepotinib 1100598-32-0 C29H28N6O2
GSK1838705A GSK1838705A 1116235-97-2 C27H29FN8O3
Levobetaxolol HCL Levobetaxolol HCL 116209-55-3 C18H30ClNO3
WZ3146 WZ3146 1214265-56-1 C24H25ClN6O2
GDC-0941 Bimesylate GDC-0941 Bimesylate 957054-33-0 C24H30N7O6S3
VU 0364770 VU 0364770 61350-00-3 C12H9ClN2O
Icotinib Icotinib 610798-31-7 C22H21N3O4
UNC2250 UNC2250 1493694-70-4 C24H36N6O2
PD168393 PD168393 194423-15-9 C17H13BrN4O
Cyclophosphamid Cyclophosphamid 50-18-0 C7H15Cl2N2O2P
Sb-742457 Sb-742457 607742-69-8 C19H19N3O2S
2-ButynaMide, N-[4-[(3-broMophenyl)aMino]-6-quinazolinyl]- 2-ButynaMide, N-[4-[(3-broMophenyl)aMino]-6-quinazolinyl]- 194423-06-8 C18H13BrN4O
VUF 10166 VUF 10166 155584-74-0 C13H15ClN4
SAR 131675 SAR 131675 1433953-83-3 C18H22N4O4
ZM 323881 hydrochloride ZM 323881 hydrochloride 193000-39-4 C22H19ClFN3O2
CNX-2006 CNX-2006 1375465-09-0 C26H27F4N7O2
SKLB1002 SKLB1002 1225451-84-2 C13H12N4O2S2
Website-Startseite | Mitglied Firmen | Werbung | ueber uns
Copyright © 2016 ChemicalBook All rights reserved.